Regorafenib Plus PD-1 Inhibitor in Patients With Colorectal Cancer
Clinical trial NCT04110093 · UNKNOWN
Trial details
- NCT number
- NCT04110093
- Sponsor
- Shanghai Changzheng Hospital
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-01
- Primary completion
- 2021-08-31
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.